Merz
在场
Merz 在 4 个国家有直接业务。
Merz 拥有 4家子公司，其中包括 Merz Aesthetics、Merz Canada 和 Merz North America。
他们在：
高管
查看带有其 45 名主要高管的组织结构图
Merz 搜索最多的简介
- Philip Burchard, Spokesman and Chief Executive Officer
- Andreas Krebs, Chairman of the Supervisory Board
- Hans Bergler, Chief Operating Officer
创建提醒
跟踪 Merz 的高管变动
药店
Merz 拥有 1,835 家竞争者，其中包括 Pfizer (美国(美洲))、Johnson & Johnson (美国(美洲)) 和 Sanofi (法国)。
Popular M&A news in 药店
- Grace Therapeutics将在Oct 24, 2024将其名称改为Grace Therapeutics。 (公布2024十月27号).
- Orasis Pharmaceuticals 刚刚宣布为 78 筹款数百万美元。 (公布2024十月21号).
- Lundbeck has announced the acquisition of Longboard Pharmaceuticals (公布2024十月17号).
药店 行业的其他推荐联系人
消息
Merz 的最新新闻稿
- Merz enters Asset Purchase Agreement with a US-based biotech company - Merz Pharma
- Merz Builds Green Factory in Reinheim - Merz Pharma
- New CEO for Merz Therapeutics: Stefan König - Merz Pharma
- New CEO for Merz Consumer Care: Xenia Barth - Merz Pharma
- XEOMIN® (incobotulinumtoxinA) Receives European Approval for the Treatment of Chronic Sialorrhea in Children - Merz Pharma
- Merz and Israeli start-up Vensica launch partnership for needleless treatment of overactive bladder - Merz Pharma
- Merz mourns for Frank Baldauf - Merz Pharma
- Teijin Receives Additional Approval in Japan for Merz’s Xeomin® Botulinum Toxin Type A - Merz Pharma
- Merz Healthcare Breaks Even Despite COVID-19 Pandemic in Fiscal Year 2019/20 - Merz Pharma
- cookie - Merz Pharma
- View more press releases Close
通过电子邮件
